Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 24 images provide visual information about the product associated with Gabapentin NDC 67296-1777 by Redpharm Drug, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

67296 1777 3

67296 1777 3

This is a description of a Gabapentin medication, which comes in the form of capsules containing 300mg of the active ingredient. The medication is distributed by Redpharm Drug and manufactured by ScieGen Pharmaceuticals in Hauppauge, NY. The lot number is 180281X1 and the medication should be stored at a controlled room temperature of 20-25 C (68-77 F). The medication has an expiration date of 07/23, and the usual adult dosage can be found in the package insert. The NDC number is 67296-1777-3.*

LABEL - 67296 1777

LABEL - 67296 1777

This is a description of a medication called Gabapentin, which comes in 300 mg and is only available with a prescription. The package contains 20 capsules, with Lot 180357X1 Exp: 10/21. The medication is meant for adult use, and the recommended dosage can be found in the package insert. It should be stored at a controlled room temperature of 20-25 C (68-77 F). The manufacturer of the medication is Sciegen Pharmaceuticals Inc, located in Hauppauge NY. The medication is distributed by Redpharm Drug, located in Eden Prairie, MN. The NDC code for this medication is 67296-1777-2.*

Gabapentin Capsules, USP 100 mg - 1,000 capsules label - gabapentin 100mg 1,000cap

Gabapentin Capsules, USP 100 mg - 1,000 capsules label - gabapentin 100mg 1,000cap

Gabapentin Capsules, USP 100 mg-100 capsules label - gabapentin 100mg 100cap

Gabapentin Capsules, USP 100 mg-100 capsules label - gabapentin 100mg 100cap

Gabapentin Capsules, USP 100 mg-30 capsules label - gabapentin 100mg 30cap

Gabapentin Capsules, USP 100 mg-30 capsules label - gabapentin 100mg 30cap

Each capsule contains 100 mg of Gabapentin, USP used as medication. The capsules are stored between 59° to 86°F and should be kept in a tight container with a child-resistant closure, as required. This medication is packaged as 30 capsules, for limited healthcare use. It is manufactured in Hauppauge, NY.*

Gabapentin Capsules, USP 100 mg-500 capsules label - gabapentin 100mg 500cap

Gabapentin Capsules, USP 100 mg-500 capsules label - gabapentin 100mg 500cap

Gabapentin Capsules, USP 300 mg - 100 capsules label - gabapentin 300mg 100cap

Gabapentin Capsules, USP 300 mg - 100 capsules label - gabapentin 300mg 100cap

Gabapentin is a medication available in the form of capsules for oral consumption under prescription only. The given text also includes some numbers and codes related to the medication and manufacturer.*

Gabapentin Capsules, USP 300 mg - 30 capsules label - gabapentin 300mg 30cap

Gabapentin Capsules, USP 300 mg - 30 capsules label - gabapentin 300mg 30cap

Gabapentin Capsules, USP are a medication that contains 300 mg of gabapentin, USP. The usual dosage and prescribing information are available and should be read before use. The medication should be stored at a temperature between 20-25°C (68-77°F), with excursions permitted between 15-30°C (59-86°F). The medication should also be kept in a tight container with 2 child-resistant closures. It is important to keep the medication and all medications out of the reach of children. This product is manufactured by ScieGen Pharmaceuticals, Hauppauge, NY, with product number NDC 50228-180-30. The revised version of this product was released in December 2017.*

Gabapentin Capsules, USP 300 mg - 500 capsules label - gabapentin 300mg 500cap

Gabapentin Capsules, USP 300 mg - 500 capsules label - gabapentin 300mg 500cap

Gabapent capsules, E25cieGen, are a prescription medication that come in a bottle of 500 capsules. The NDC number for this medication is 50228-180-05. The rest of the text appears to be illegible or not relevant to the medication description.*

Gabapentin Capsules, USP 400 mg - 100 capsules label - gabapentin 400mg 100cap

Gabapentin Capsules, USP 400 mg - 100 capsules label - gabapentin 400mg 100cap

Gabapentin Capsules, USP 400 mg - 30 capsules label - gabapentin 400mg 30cap

Gabapentin Capsules, USP 400 mg - 30 capsules label - gabapentin 400mg 30cap

Gabapentin Capsules are medication capsules that contain 400 mg of USP-grade gabapentin to treat certain types of nerve pain by decreasing the severity of seizures, particularly those occurring in epilepsy. The recommended dose of this medication and other important details necessary for proper administration are sent alongside the prescription. These capsules should be stored at room temperature and away from kids. It is critical to keep all medicines in the same place to prevent misuse. This medication is manufactured by Sciegen Pharmaceuticals, located in Hauppauge, NY.*

Gabapentin Capsules, USP 400 mg - 500 capsules label - gabapentin 400mg 500cap

Gabapentin Capsules, USP 400 mg - 500 capsules label - gabapentin 400mg 500cap

Gabapentin Tablets, USP 600 mg - 100 Tablets label - gabapentin 600mg 100tab

Gabapentin Tablets, USP 600 mg - 100 Tablets label - gabapentin 600mg 100tab

This appears to be a label or packaging information for a prescription medication called Gabapent, available in 600mg tablets. The label includes a unique identification number (NDC 50228-177-01) and a prescription symbol (Rx). There are other numbers and characters present, possibly related to production or distribution of the medication.*

Gabapentin Tablets, USP 600 mg - 30 Tablets label - gabapentin 600mg 30tab

Gabapentin Tablets, USP 600 mg - 30 Tablets label - gabapentin 600mg 30tab

Each tablet contains 600 mg of gabapentin, which is a medication used to treat epilepsy and nerve pain. The tablets are produced by ScieGen Pharmaceuticals Inc. and are dispensed in a tightly sealed container with child-resistant closure. They should be stored between 59°F to 86°F and must not be exposed to temperatures above 30°C (86°F). The NDC (National Drug Code) for this medication is 50228-177-30.*

Gabapentin Tablets, USP 600 mg - 500 Tablets label - gabapentin 600mg 500tab

Gabapentin Tablets, USP 600 mg - 500 Tablets label - gabapentin 600mg 500tab

This is a description of a pharmaceutical advertisement for Gabapentin tablets. The ad provides product information such as the manufacturer, quantity (500 tablets), and that it is a prescription drug (Rx only). However, some of the text is not readable due to errors.*

Gabapentin Tablets, USP 800 mg - 100 Tablets label - gabapentin 800mg 100tab

Gabapentin Tablets, USP 800 mg - 100 Tablets label - gabapentin 800mg 100tab

Gabapentin Tablets, USP 800 mg - 30 Tablets label - gabapentin 800mg 30tab

Gabapentin Tablets, USP 800 mg - 30 Tablets label - gabapentin 800mg 30tab

Gabapentin is a prescription medication in tablet form containing 800mg of gabapentin, USP. It is important to store the tablets at recommended temperatures, dispense them in child-resistant containers, and keep them out of children's reach. The usual dosage is provided in the accompanying prescribing information. The tablets are manufactured by ScieGen Pharmaceuticals, Inc. in Hauppauge, NY. The label includes a lot number, expiration date, and NDC code.*

Gabapentin Tablets, USP 800 mg - 500 Tablets label - gabapentin 800mg 500tab

Gabapentin Tablets, USP 800 mg - 500 Tablets label - gabapentin 800mg 500tab

This is the description of Gabapent Tablets, which are available only by prescription (Rx only). The National Drug Code (NDC) for the medication is 50228-178-05. The remaining text is not readable due to errors.*

Figure 1 - image 01

Figure 1 - image 01

Figure 2 - image 02

Figure 2 - image 02

This appears to be a graph of a study looking at the effectiveness of Gabapentin at different doses in reducing pain over a 4-week period. The x-axis represents the 4-week period, and the y-axis shows the mean pain score. Three groups were studied: a placebo group, a group taking Gabapentin at 1800 mg/day, and a group taking Gabapentin at 2400 mg/day. The graph shows that both Gabapentin groups experienced a decrease in pain score compared to the placebo group. However, the group taking 2400 mg/day had a greater reduction in pain compared to the group taking 1800 mg/day.*

Figure 3 - image 03

Figure 3 - image 03

Cockcroft and Gault Equation - image 04

Cockcroft and Gault Equation - image 04

Gabapentin Structural Formula - image 05

Gabapentin Structural Formula - image 05

Figure 4. Responder Rate in Patients Receiving gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - image 09

Figure 4. Responder Rate in Patients Receiving gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - image 09

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.